Free Trial

BriaCell Therapeutics (BCTXW) Competitors

BriaCell Therapeutics logo
$0.06 -0.01 (-14.77%)
As of 07/7/2025 01:23 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BCTXW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, AMPE, ACABW, BFRIW, BTMDW, and CALA

Should you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Ampio Pharmaceuticals (AMPE), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.

BriaCell Therapeutics vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and BriaCell Therapeutics (NASDAQ:BCTXW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, media sentiment and dividends.

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled BriaCell Therapeutics'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
BriaCell Therapeutics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
BriaCell TherapeuticsN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
BriaCell Therapeutics N/A N/A N/A

Summary

180 Life Sciences and BriaCell Therapeutics tied by winning 0 of the 0 factors compared between the two stocks.

Get BriaCell Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCTXW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BCTXW vs. The Competition

MetricBriaCell TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$127.85M$5.52B$9.02B
Dividend YieldN/A3.74%5.24%4.08%
P/E RatioN/A3.3827.1920.04
Price / SalesN/A4,297.76413.81108.84
Price / CashN/A13.1926.2128.59
Price / BookN/A42.057.925.55
Net IncomeN/A-$92.79M$3.17B$248.49M
7 Day PerformanceN/A8.61%1.78%4.87%
1 Month PerformanceN/A2.97%1.26%6.63%
1 Year PerformanceN/A180.51%33.30%20.38%

BriaCell Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BCTXW
BriaCell Therapeutics
N/A$0.06
-14.8%
N/A-71.1%$0.00N/A0.008
ATNFW
180 Life Sciences
N/A$0.01
+7.5%
N/A-4.6%$0.00N/A0.007Positive News
Gap Up
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/A-80.9%$0.00N/A0.002
AIMDW
Ainos
N/A$0.13
-13.3%
N/AN/A$0.00$106.21K0.0040Gap Down
ALVOW
Alvotech
N/A$1.73
+1.8%
N/A-36.2%$0.00$585.60M0.004Positive News
AMPE
Ampio Pharmaceuticals
0.1435 of 5 stars
$0.00
-96.3%
N/A-96.0%$0.00N/A0.0020Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
-0.5%
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.11
+16.9%
N/A+157.7%$0.00$38.00M0.0070Positive News
Gap Up
BTMDW
biote
N/A$0.01
+24.5%
N/AN/A$0.00$199.38M0.00N/AGap Down
CALA
Calithera Biosciences
N/A$0.00
-90.0%
N/A-99.0%$0.00N/A0.0060

Related Companies and Tools


This page (NASDAQ:BCTXW) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners